Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Apple
AAPL
|
+$953M |
| 2 |
NVIDIA
NVDA
|
+$784M |
| 3 |
Meta Platforms (Facebook)
META
|
+$753M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$316M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$315M |
Top Sells
| 1 |
Amazon
AMZN
|
+$1.17B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$506M |
| 4 |
Abbott
ABT
|
+$388M |
| 5 |
Johnson & Johnson
JNJ
|
+$325M |
Sector Composition
| 1 | Technology | 20.29% |
| 2 | Healthcare | 16.94% |
| 3 | Consumer Discretionary | 12.83% |
| 4 | Consumer Staples | 9.16% |
| 5 | Industrials | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3301
iShares US Infrastructure ETF
IFRA
$3.02B
| $203K | ﹤0.01% |
+5,200
| New | +$203K |
|
3302
AquaBounty Technologies
AQB
$4.46M
| $202K | ﹤0.01% |
28,470
-5,410
| -16% | -$38.4K |
|
|
CBIO
3303
Crescent Biopharma, Inc. Common Stock
CBIO
$174M
| $202K | ﹤0.01% |
1,161
-270
| -19% | -$47K |
|
3304
HF Foods Group
HFFG
$183M
| $201K | ﹤0.01% |
42,900
+5,800
| +16% | +$27.2K |
|
3305
Protara Therapeutics
TARA
$123M
| $200K | ﹤0.01% |
83,600
+24,694
| +42% | +$59.1K |
|
3306
P3 Health Partners
PIII
$28.3M
| $199K | ﹤0.01% |
+1,331
| New | +$199K |
|
3307
Beam Global
BEEM
$42.9M
| $198K | ﹤0.01% |
+19,100
| New | +$198K |
|
3308
Mayville Engineering Co
MEC
$295M
| $198K | ﹤0.01% |
+15,900
| New | +$198K |
|
3309
electroCore
ECOR
$38.1M
| $197K | ﹤0.01% |
40,305
+11,061
| +38% | +$54.1K |
|
|
ODV
3310
Osisko Development Corp
ODV
$742M
| $196K | ﹤0.01% |
42,700
+21,100
| +98% | +$96.9K |
|
|
ICD
3311
DELISTED
Independence Contract Drilling, Inc.
ICD
| $196K | ﹤0.01% |
71,844
-60,924
| -46% | -$166K |
|
3312
a.k.a. Brands
AKA
$114M
| $191K | ﹤0.01% |
37,000
+28,983
| +362% | +$150K |
|
3313
American Shared Hospital Services
AMS
$15.6M
| $191K | ﹤0.01% |
74,795
+29,595
| +65% | +$75.6K |
|
3314
Companhia Siderúrgica Nacional
SID
$1.99B
| $191K | ﹤0.01% |
73,700
-362,813
| -83% | -$940K |
|
|
WKME
3315
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
| $191K | ﹤0.01% |
19,900
+2,700
| +16% | +$25.9K |
|
3316
Anixa Biosciences
ANIX
$95M
| $190K | ﹤0.01% |
59,300
+37,998
| +178% | +$122K |
|
|
VIRX
3317
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $190K | ﹤0.01% |
134,799
+9,500
| +8% | +$13.4K |
|
3318
KORE Group Holdings
KORE
$37.4M
| $189K | ﹤0.01% |
31,060
+22,340
| +256% | +$136K |
|
|
TMQ
3319
Trilogy Metals
TMQ
$351M
| $188K | ﹤0.01% |
317,300
+198,800
| +168% | +$118K |
|
3320
Palladyne AI
PDYN
$300M
| $188K | ﹤0.01% |
97,240
-1,647
| -2% | -$3.18K |
|
3321
GDS Holdings
GDS
$7.37B
| $187K | ﹤0.01% |
17,000
+1,000
| +6% | +$11K |
|
|
GRCL
3322
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $187K | ﹤0.01% |
49,100
+200
| +0.4% | +$762 |
|
3323
Richmond Mutual Bancorp
RMBI
$141M
| $184K | ﹤0.01% |
16,642
+500
| +3% | +$5.53K |
|
3324
INmune Bio
INMB
$52.4M
| $182K | ﹤0.01% |
20,000
-14,800
| -43% | -$135K |
|
|
NETI
3325
DELISTED
Eneti Inc.
NETI
| $182K | ﹤0.01% |
15,000
-86,209
| -85% | -$1.05M |
|